BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferreira S, Saraiva N, Rijo P, Fernandes AS. LOXL2 Inhibitors and Breast Cancer Progression. Antioxidants (Basel) 2021;10:312. [PMID: 33669630 DOI: 10.3390/antiox10020312] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Zamborlin A, Voliani V. Gold nanoparticles as antiangiogenic and antimetastatic agents. Drug Discov Today 2023;28:103438. [PMID: 36375738 DOI: 10.1016/j.drudis.2022.103438] [Reference Citation Analysis]
2 Gelman IH. The genomic regulation of metastatic dormancy. Cancer Metastasis Rev 2023. [PMID: 36600151 DOI: 10.1007/s10555-022-10076-w] [Reference Citation Analysis]
3 Abozaid OAR, Rashed LA, El-Sonbaty SM, Abu-Elftouh AI, Ahmed ESA. Mesenchymal Stem Cells and Selenium Nanoparticles Synergize with Low Dose of Gamma Radiation to Suppress Mammary Gland Carcinogenesis via Regulation of Tumor Microenvironment. Biol Trace Elem Res 2023;201:338-52. [PMID: 35138531 DOI: 10.1007/s12011-022-03146-1] [Reference Citation Analysis]
4 Ezhilarasan D, Najimi M. Intercellular communication among liver cells in the perisinusoidal space of the injured liver: Pathophysiology and therapeutic directions. J Cell Physiol 2023;238:70-81. [PMID: 36409708 DOI: 10.1002/jcp.30915] [Reference Citation Analysis]
5 Wang W, Wang X, Yao F, Huang C. Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer. Int J Mol Sci 2022;23:12270. [PMID: 36293126 DOI: 10.3390/ijms232012270] [Reference Citation Analysis]
6 Baldari S, Di Modugno F, Nisticò P, Toietta G. Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy. Cancers 2022;14:4706. [DOI: 10.3390/cancers14194706] [Reference Citation Analysis]
7 Cui Y, Wang X, Zhang L, Liu W, Ning J, Gu R, Cui Y, Cai L, Xing Y. A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma. Front Oncol 2022;12:974614. [DOI: 10.3389/fonc.2022.974614] [Reference Citation Analysis]
8 Nishi K, Fu W, Kiyama R. Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity. PLoS ONE 2022;17:e0273164. [DOI: 10.1371/journal.pone.0273164] [Reference Citation Analysis]
9 Jurenaite N, Leon-perinan D, Donath V, Torge S, Jakel R. SetQuence & SetOmic: Deep Set Transformer-based Representations of Cancer Multi-Omics. 2022 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) 2022. [DOI: 10.1109/cibcb55180.2022.9863058] [Reference Citation Analysis]
10 Gong L, Zhang Y, Yang Y, Yan Q, Ren J, Luo J, Tiu YC, Fang X, Liu B, Lam RHW, Lam KO, Lee AW, Guan XY. Inhibition of lysyl oxidase-like 2 overcomes adhesion-dependent drug resistance in the collagen-enriched liver cancer microenvironment. Hepatol Commun 2022;6:3194-211. [PMID: 35894804 DOI: 10.1002/hep4.1966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ramos S, Ferreira S, Fernandes AS, Saraiva N. Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis. Front Pharmacol 2022;13:883998. [DOI: 10.3389/fphar.2022.883998] [Reference Citation Analysis]
12 Migulina N, Tjin G, Faiz A, Borghuis T, Zhao F, Kaper HJ, Metzlar M, van Dijk E, Sharma PK, Timens W, Gosens R, Brandsma CA, Burgess JK. Differential roles for lysyl oxidase (like), family members in chronic obstructive pulmonary disease; from gene and protein expression to function. FASEB J 2022;36:e22374. [PMID: 35670745 DOI: 10.1096/fj.202101553R] [Reference Citation Analysis]
13 Fernandes AS. Redox-Active Molecules as Therapeutic Agents. Antioxidants 2022;11:1004. [DOI: 10.3390/antiox11051004] [Reference Citation Analysis]
14 Null JL, Kim DJ, Mccann JV, Pramoonjago P, Fox JW, Kumar P, Edatt L, Pecot CV, Dudley AC. Periostin+ stromal cells guide lymphovascular invasion by cancer cells.. [DOI: 10.1101/2022.05.19.492742] [Reference Citation Analysis]
15 Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol 2022;15:34. [PMID: 35331296 DOI: 10.1186/s13045-022-01252-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
16 Sun C, Ma S, Chen Y, Kim NH, Kailas S, Wang Y, Gu W, Chen Y, Tuason JPW, Bhan C, Manem N, Huang Y, Cheng C, Zhou Z, Zhou Q, Zhu Y. Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis. Front Oncol 2022;12:843880. [DOI: 10.3389/fonc.2022.843880] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Gorka J, Marona P, Kwapisz O, Rys J, Jura J, Miekus K. MCPIP1 regulates focal adhesion kinase and rho GTPase-dependent migration in clear cell renal cell carcinoma. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174804] [Reference Citation Analysis]
18 Alfano M, Locatelli I, D'Arrigo C, Mora M, Vozzi G, De Acutis A, Pece R, Tavella S, Costa D, Poggi A, Zocchi MR. Lysyl-Oxidase Dependent Extracellular Matrix Stiffness in Hodgkin Lymphomas: Mechanical and Topographical Evidence. Cancers (Basel) 2022;14:259. [PMID: 35008423 DOI: 10.3390/cancers14010259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Nirgude S, Desai S, Choudhary B. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis. Cancer Rep (Hoboken) 2022;:e1596. [PMID: 34981672 DOI: 10.1002/cnr2.1596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kumari S, Patro ARK, Mishra B, Jena SK, Singh S. Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population. Diagnostics 2022;12:53. [DOI: 10.3390/diagnostics12010053] [Reference Citation Analysis]
21 Vaish U, Jain T, Are AC, Dudeja V. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting. Int J Mol Sci 2021;22:13408. [PMID: 34948209 DOI: 10.3390/ijms222413408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
22 Mason LD, Chava S, Reddi KK, Gupta R. The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis. Cancers (Basel) 2021;13:5516. [PMID: 34771678 DOI: 10.3390/cancers13215516] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Wen L, Hu J, Zhang J, Yang J. Phenylethanol glycosides from Herba Cistanche improve the hypoxic tumor microenvironment and enhance the effects of oxaliplatin via the HIF‑1α signaling pathway. Mol Med Rep 2021;24:517. [PMID: 34013363 DOI: 10.3892/mmr.2021.12156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Deng Y, Chakraborty P, Jolly MK, Levine H. A Theoretical Approach to Coupling the Epithelial-Mesenchymal Transition (EMT) to Extracellular Matrix (ECM) Stiffness via LOXL2. Cancers (Basel) 2021;13:1609. [PMID: 33807227 DOI: 10.3390/cancers13071609] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]